Description
+ Include: 19 videos + 1 pdf, size: 6.91 GB
+ Target Audience: cardiovascular specialists, heart failure specialists, practicing cardiologists, cardiovascular advanced practice providers (NP or PA), internists, family physicians
+ Sample video: contact me for sample video
+ Information:
Charleston HFpEF Conference
The Latest Knowledge on Heart Failure with preserved Ejection Fraction
JULY 28-30, 2023
TARGET AUDIENCE
This course is intended for cardiovascular specialists, heart failure specialists, practicing cardiologists, cardiovascular advanced practice providers (NP or PA), internists, family physicians, pharmacist, cardiovascular nurses, critical care nurses, and industry representatives.
KNOWLEDGE GAPS
There are now more patients who have Heart Failure with preserved Ejection Fraction (HFpEF) than those with reduced Ejection Fraction (HFrEF). Making the diagnosis of HFpEF is more challenging than HFrEF as many commonly used screening tools such as physical examination, echocardiography and measurement of natriuretic peptide levels are less sensitive and specifc in this population. Most importantly, most therapies studied have not been shown to improve major cardiovascular outcome, and those that have shown reductions in heart failure hospitalizations have modest absolute reductions and little or no improvement in quality of life metrics.
CONFERENCE OBJECTIVES
At the completion of this conference, participants should be able to:
1. Review the latest evidence on the optimal choices of diuretics in heart failure.
2. Discuss new approaches to giving advice about sodium and fuid restriction in patients with heart failure.
3. Efectively prescribe medications for weight management in patients with HFpEF
4. Engage in shared decision making with your patients about the value of newer treatments
5. Discuss the mechanisms of diastolic dysfunction in patients with HFpEF
6. Design and implement a HF clinic for follow up of recently hospitalized HF patients
+ Topics:
AF Management in HFpEF Does Ablation Make Things Worse or Better.mp4
Application and Interpretation of Common Patient Reported Outcome Measures Used in Heart Failure Clinical Trials.mp4
Artificial Intelligence in the Diagnosis and Treatment of HFpEF.mp4
Ask the Experts Challenges in HFpEF Management and Diagnosis (Is it HF or age HFpEF with Severe Obesity; Concomitant Lung Disease; Pulmonary HT.mp4
Coronary Microvascular Disease in HFpEF Pathophysiology, Diagnosis and Management.mp4
Exercise Training as Therapy for HFpEF How Does it Work What Type is Best.mp4
From Clinical Trials to Individual Patients A Primer on Shared Decision Making.mp4
HFpEF2023.pdf
Hypertrophic Cardiomyopathy as a Form of HFpEF Diagnosis, Drugs and Procedures.mp4
Mechanisms of Diastolic Dysfunction (Fibrosis, Myofilaments, etc) and How to Make Them Therapeutic Targets.mp4
Opti-Volemia When Is Your Patient Ready for Discharge.mp4
POTS and Reverse-POTS in HFpEF- Recognizing and Managing Inadequate Preload Reserve.mp4
Stimulating Therapies for HFpEF CCM, Barostimulation, Phrenic Nerve Stimulation, Etc.mp4
The Evolving Feld of Atrial Shunt Therapies for HFpEF the Holey Grail.mp4
Tips on How to Set and Run a Post-Hospital Discharge Heart Failure Clinic.mp4
Top HFpEF Papers of the Year.mp4
Update on Cardiac Amyloid.mp4
Valve Issues in HFpEF The Patient Who is Still Short of Breath After TAVR; Who Needs Tricuspid Valve Clipping.mp4
Weight Loss as Treatment for HFpEF An Update on Drugs and Procedures.mp4
Which Diuretic(s) are Best in HF Update Based on Recent Clinical Trials.mp4
Reviews
There are no reviews yet.